Sequential Hypofractionated versus Concurrent Twice-Daily Radiotherapy for Limited-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
Wei ZhouPang WangXinyu TiYutian YinShi-Gao HuangZhi YangJie LiGuangjin ChaiBo LyuZhaohui LiYan ZhouFeng XiaoLin XuMei ShiLina ZhaoPublished in: Cancers (2022)
After propensity matching, no difference was shown in survival and failure. The sequential hypo schedule was associated with comparable survival and less toxicity and may be used as an alternative to concurrent twice-daily regimens.